News
CATB
--
0.00%
--
Catabasis names Noah Clauser as CFO
Catabasis Pharmaceuticals (CATB) promotes Noah Clauser to Chief Financial Officer; he has been with Catabasis for 9 years, most recently as Vice President, Finance.Prior to joining Catabasis, Mr. Clauser worked at Impress Software,
Seekingalpha · 1d ago
Is Catabasis Pharmaceuticals (NASDAQ:CATB) In A Good Position To Deliver On Growth Plans?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Simply Wall St. · 09/10 13:51
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences
Business Wire · 09/08 13:00
Are Options Traders Betting on a Big Move in Catabasis (CATB) Stock?
Investors need to pay close attention to Catabasis (CATB) stock based on the movements in the options market lately.
Zacks · 09/03 12:41
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy
Business Wire · 09/02 13:00
Catabasis Pharmaceuticals (CATB) Surges: Stock Moves 8.6% Higher
Catabasis Pharmaceuticals (CATB) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Zacks · 08/25 13:38
Oppenheimer Says These 2 Stocks Could Surge Over 100% From Current Levels
The U.S. presidential election is only a few months away, and you know what that means. It's time for the national conventions. This week, Wall Street’s focus has locked in on the race to the White House as the Democratic National Convention kicked off, with the Republican gathering taking place
TipRanks · 08/21 15:35
Catabasis Pharmaceuticals (CATB) Investor Presentation - Slideshow
The following slide deck was published by Catabasis Pharmaceuticals, Inc. in conjunction with this event.
Seekingalpha · 08/11 19:30
Catabasis Pharmaceuticals (CATB) Investor Presentation - Slideshow
The following slide deck was published by Catabasis Pharmaceuticals, Inc. in conjunction with this event.
Seekingalpha · 08/11 19:30
Catabasis Pharmaceuticals (CATB) Investor Presentation - Slideshow
The following slide deck was published by Catabasis Pharmaceuticals, Inc. in conjunction with this event.
Seekingalpha · 08/11 19:30
Catabasis Pharmaceuticals (CATB) Investor Presentation - Slideshow
Seeking Alpha - Article · 08/11 19:30
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress
Business Wire · 08/10 21:10
Catabasis Pharmaceuticals Q2 EPS $(0.53) Misses $(0.45) Estimate
Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.45) by 17.78 percent. This is a 14.52 percent increase over losses of $(0.62) per
Benzinga · 08/10 20:38
Catabasis Pharmaceuticals to Present at Virtual 2020 Wedbush PacGrow Healthcare Conference
Business Wire · 08/05 13:00
Catabasis Pharmaceuticals and Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive and Drug-Resistant Tuberculosis
Business Wire · 08/04 13:00
Catabasis Pharmaceuticals And Bill & Melinda Gates Medical Research Institute To Study CAT-5571 In Drug-Sensitive And Drug-Resistant Tuberculosis
Benzinga · 08/04 12:06
Catabasis Pharmaceuticals to Report Second Quarter 2020 Financial Results on Monday, August 10th
Business Wire · 07/27 13:00
Catabasis Pharmaceuticals to Present at Parent Project Muscular Dystrophy Virtual Annual Conference
Business Wire · 07/15 13:00
Catabasis Joins Russell 3000® Index
Business Wire · 06/29 21:10
Catabasis Pharma Reports Joined Russell 3000 Index At Market Open Today
Benzinga · 06/29 20:10